Cargando…
Fatostatin induces pro- and anti-apoptotic lipid accumulation in breast cancer
Given the dependence of cancers on de novo lipogenesis, we tested the effect of fatostatin, a small molecule thought to target this pathway by blocking activation of SREBP transcription factors, in breast cancer cell lines and xenograft tumors. We found that estrogen receptor (ER) positive cells wer...
Autores principales: | Brovkovych, Viktor, Izhar, Yasir, Danes, Jeanne M., Dubrovskyi, Oleskii, Sakallioglu, Isin T., Morrow, Lauren M., Atilla-Gokcumen, G. Ekin, Frasor, Jonna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107643/ https://www.ncbi.nlm.nih.gov/pubmed/30140005 http://dx.doi.org/10.1038/s41389-018-0076-0 |
Ejemplares similares
-
Emerging Roles of Ceramides in Breast Cancer Biology and Therapy
por: Pal, Purab, et al.
Publicado: (2022) -
SREBP activation contributes to fatty acid accumulations in necroptosis
por: Lu, Daniel, et al.
Publicado: (2023) -
Fatostatin ameliorates inflammation without affecting cell viability
por: Ma, Shuhe, et al.
Publicado: (2022) -
Histone deacetylase inhibitor-based chromatin precipitation for identification of targeted genomic loci
por: Hanigan, Thomas W., et al.
Publicado: (2018) -
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells
por: Pal, Purab, et al.
Publicado: (2022)